EN 
FR -
Linearis Opens its New Laboratory Offering an AI Biomarkers Analytical Platform for Innovation Against Cancer, Diabetes, Antimicrobial Resistance, and Other Metabolic Diseases
https://vimeo.com/983745132 Leveraging artificial intelligence (AI), Linearis provides a comprehensive health status based on the analysis of ∼1,300 metabolomic biomarkers through mass spectrometry. The platform will enable its clients to improve prevention, screening, treatment monitoring, and new drug discovery. Québec, Canada, November 28, 2023- Linearis Labs Inc (“Linearis”), an innovative company at the intersection of AI…